Actinium Pharmaceuticals, Inc.
AMEX:ATNMBiotechnology
Healthcare
$1.64 +15.94%
+$0.22 today
- Market cap
- $51.56M
- Beta
- 0.02
- P/E (TTM)
- 4.4
- EPS (TTM)
- $0.36
52W Low $0.74High $1.74
Volume 0.18M
Average 0.15M
Balance Sheet
Inspect the capital base behind the business.
Assets
$51.77M
FY 2025 · Annual
-32.7% YoYLiabilities
$43.94M
FY 2025 · Annual
-0.5% YoYEquity
$7.83M
FY 2025 · Annual
-76.1% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 77.83M | 108.91M | 76.68M | 72.9M | 48M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 442K | 396K | 226K | 357K | 1.38M |
| Total Current Assets | 79.75M | 110.94M | 78.26M | 74.51M | 49.38M |
| Property, Plant & Equipment (Net) | 639K | 2.95M | 2.87M | 2.07M | 2.06M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 313K | 324K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 302K | 0 | 0 | 335K |
| Total Non-current Assets | 639K | 3.25M | 3.18M | 2.39M | 2.39M |
| Total Assets | 80.39M | 114.19M | 81.45M | 76.9M | 51.78M |
| Account Payables | 5.54M | 10.13M | 7.95M | 7.57M | 0 |
| Short-term Debt | 0 | 0 | 541K | 0 | 722K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 35M |
| Other Current Liabilities | 998K | 0 | 0 | 0 | (27.75M) |
| Total Current Liabilities | 6.84M | 10.63M | 8.49M | 8.15M | 7.97M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 35M | 35M | 35M |
| Other Non-current Liabilities | 0 | 35M | 0 | 0 | 0 |
| Total Non-current Liabilities | 3K | 37.08M | 36.57M | 35.99M | 35.97M |
| Total Liabilities | 6.84M | 47.71M | 45.07M | 44.14M | 43.94M |
| Common Stock | 22K | 26K | 28K | 31K | 31K |
| Retained Earnings | (255.75M) | (288.77M) | (337.58M) | (375.83M) | (409.71M) |
| Accumulated OCI | (0) | (0) | 0 | 0 | (20K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 73.55M | 66.48M | 36.38M | 32.76M | 7.83M |
| Total Debt | 310K | 2.58M | 2.11M | 1.57M | 1.69M |
| Net Debt | (77.52M) | (106.33M) | (74.56M) | (71.33M) | (46.3M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $36.5M |
| Other Current | $1.3M |
| Total Current Assets | $37.7M |
| PP&E (Net) | $700.0K |
| Other Non-current | $1.7M |
| Total Non-current Assets | $2.4M |
| Total Assets | $40.2M |
Analysis
Selected assets total $40.2M for Latest. The largest visible component is Cash & Equivalents at $36.5M, about 90.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 3 | Initial statement of beneficial ownership | Oct 16, 2026 | |
| 8-K | Current report | Oct 15, 2026 | |
| DEF 14A | DEF 14A filing | Oct 15, 2026 | |
| ARS | ARS filing | Oct 15, 2026 |
How much cash does ATNM have?
Actinium Pharmaceuticals, Inc. (ATNM) reported $48.00M in cash and equivalents in fiscal 2025.
How much debt does ATNM carry?
Actinium Pharmaceuticals, Inc. (ATNM) reported $1.69M of total debt, with net debt of -$46.30M.
Continue the stock analysis
Jump to another research area for this company.